1-5 of 5
Ariane C. Mineur
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dexaml-02 : A Phase II Study of Dexamethasone Added to Induction and Postremission Therapy in Older Patients with Newly Diagnosed AML. a French Innovative Leukemia Organization (FILO) Study

Christian Recher, Sarah Bertoli, Pierre Peterlin, Romain Guieze, Yohan Desbrosses, Yosr Hicheri, Omar Benbrahim, Martin Carre, Hunault-Berger Mathilde, Anne Banos, Marc Bernard, Emmanuel Gyan, Alain Saad, Safia Chebrek, Gabrielle Roth Guepin, Veronique Dorvaux, Laurence Sanhes, Maria Pilar Gallego Hernanz, Carole Exbrayat, Laure Vincent, Chantal Himberlin, Laetitia Largeaud, Eric Delabesse, Francois Vergez, Norbert Vey, Ariane C Mineur, Célestine Simand, Isabelle Luquet, Arnaud Pigneux
Journal: Blood
Blood (2022) 140 (Supplement 1): 6149–6151.
https://doi.org/10.1182/blood-2022-158665
Published: 2022
Journal Articles

Gilteritinib Activity in Refractory or Relapsed FLT3 -Mutated Acute Myeloid Leukemia Patients Previously Treated By Intensive Chemotherapy and Midostaurin: A Study from the French AML Intergroup ALFA/Filo

Pierre-Yves Dumas, Emmanuel Raffoux, Emilie Berard, Sarah Bertoli, Marie Anne Hospital, Mael Heiblig, Yohan Desbrosses, Caroline Bonmati, Cecile Pautas, Juliette Lambert, Corentin Orvain, Anne Banos, Florence Pasquier, Pierre Peterlin, Tony Marchand, Madalina Uzunov, Jamilé Frayfer, Pascal Turlure, Thomas Cluzeau, Eric Jourdan, Chantal Himberlin, Emmanuelle Tavernier, Alban Villate, Stéphanie Haiat, Marie-Lorraine Chretien, Martin Carre, Sylvain Chantepie, Iona Vaida, Mathieu Wemeau, Safia Chebrek, Gaëlle Guillerm, Romain Guieze, Houria Debarri, Eve Gehlkopf, Kamel Laribi, Ambroise Marçais, Alberto Santagostino, Marie C Bene, Ariane C Mineur, Arnaud Pigneux, Herve Dombret, Christian Recher
Journal: Blood
Blood (2022) 140 (Supplement 1): 8996–8998.
https://doi.org/10.1182/blood-2022-159125
Published: 2022
Journal Articles

Comparison of a Combination of Vosaroxin (VOS) and Intermediate-Dose Cytarabine (IDAC) with Idac for the Consolidation Therapy of Younger Patients with Favorable- and Intermediate-Risk Acute Myeloid Leukemia (AML) in First Complete Remission (CR): Preliminary Results of a Randomized Phase 2 R4-VOS Study of the French ALFA-Filo AML Intergroup

Norbert Vey, MD, Corentin Orvain, MD PhD, Christian Recher, MD PhD, Arnaud Pigneux, MD PhD, Marc Bernard, MD, Anne Banos, MD, Pierre Peterlin, MD, Sylvain Chantepie, MD, Xavier Thomas, MD PhD, Cecile Pautas, MD, Claude Gardin, Emilie Lemasle, MD, Emmanuel Raffoux, MD, Romain Guieze, MD, Chantal Himberlin, MD, Clémence Loiseau, MD, Amine Belhabri, MD, Isabelle Luquet, MD, Christine Terré, PharmD, PhD, Martin Carre, MD, Claude Preudhomme, MD PhD, Eric Delabesse, MD PhD, Karine Celli-Lebras, CRA, Ariane C Mineur, CRA, Jean-Francois Brasme, MD PhD, Jean Francois Hamel, MD, Hervé Dombret, MD, Mathilde Hunault, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-137032
Published: 2020
Journal Articles

Addition of Lomustine in the Treatment of Elderly Patients with Acute Myeloblastic Leukemia Improves Survival with Acceptably Increased Infectious Toxicity. a Filo Study

Pilar Gallego-Hernanz, MD, Marie C Bene, PharmSciD, PhD, Pierre-Yves Dumas, MD, Jacques Delaunay, MD, Caroline Bonmati, MD, Romain Guieze, MD PhD, Isabelle Luquet, MD, Pascale Cornillet-Lefebvre, Eric Delabesse, MDPhD, Jean-Christophe Ianotto, MD, Mario Ojeda, MD, Mathilde Hunault, MD PhD, Anne Banos, MD, Bruno Lioure, MD, Marc Bernard, MD, Eric Jourdan, MD, Norbert Vey, Hacene Zerazhi, Yosr Hicheri, Ariane C Mineur, Roselyne Delepine, Jean Yves Cahn, MD PhD, Norbert Ifrah, MD, Christian Recher, MD PhD, Arnaud Pigneux, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2587.
https://doi.org/10.1182/blood.V130.Suppl_1.2587.2587
Published: 2017
Journal Articles

Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial

Arnaud Pigneux, Christian Recher, MDPhD, Marie C Bene, PharmSciD, PhD, Julien Asselineau, PhD, Ariane C. Mineur, Thibaut Leguay, MD, Jacques Delaunay, MD, Caroline Bonmati, MD, Romain Guieze, MD, Isabelle Luquet, MD, Pascale Cornillet-Lefebvre, MD, Catherine Lacombe, MDPhD, jean-Christophe Ianotto, MD, Mario Ojeda, MD, Mathilde Hunault, MDPhD, Anne Banos, MD, Bruno Lioure, MD, Marc Bernard, MD, Eric Jourdan, MDPhD, Norbert Vey, Hacene Zerazhi, MD, Hichri Yosr, MD, Roselyne Delepine, Rachid Salmi, MDPhD, Francois Dreyfus, MD, Jean-Yves Cahn, Norbert Ifrah, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3736.
https://doi.org/10.1182/blood.V126.23.3736.3736
Published: 2015